Shares of Integer Holdings Corporation (NYSE:ITGR - Get Free Report) have been assigned a consensus recommendation of "Hold" from the fourteen research firms that are covering the company, MarketBeat.com reports. Thirteen equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price target among brokers that have covered the stock in the last year is $109.8571.
Several research firms have recently weighed in on ITGR. Weiss Ratings reiterated a "hold (c)" rating on shares of Integer in a research note on Thursday, June 18th. KeyCorp cut Integer from an "overweight" rating to a "sector weight" rating in a research note on Monday, August 3rd. Truist Financial lowered Integer from a "buy" rating to a "hold" rating and upped their target price for the stock from $110.00 to $127.00 in a research report on Monday, August 3rd. Zacks Research upgraded Integer from a "strong sell" rating to a "hold" rating in a report on Monday, July 20th. Finally, Benchmark lowered shares of Integer from a "buy" rating to a "hold" rating in a research note on Thursday, August 13th.
Get Our Latest Analysis on ITGR
Insider Activity at Integer
In other news, insider Andrew Senn sold 9,408 shares of the business's stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $126.30, for a total transaction of $1,188,230.40. Following the completion of the sale, the insider directly owned 5,405 shares of the company's stock, valued at $682,651.50. The trade was a 63.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.10% of the stock is currently owned by insiders.
Institutional Trading of Integer
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Integer by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider's stock valued at $2,539,000 after buying an additional 837 shares during the last quarter. Millennium Management LLC lifted its stake in Integer by 2,408.8% during the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider's stock valued at $14,531,000 after acquiring an additional 118,224 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Integer by 79,888.9% during the 1st quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider's stock valued at $850,000 after acquiring an additional 7,190 shares in the last quarter. United Services Automobile Association purchased a new position in Integer during the 1st quarter worth $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Integer by 4.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider's stock worth $12,900,000 after acquiring an additional 4,873 shares during the last quarter. 99.29% of the stock is owned by institutional investors.
Integer Stock Up 0.0%
Shares of Integer stock opened at $126.06 on Friday. The stock's 50-day moving average is $114.21 and its 200 day moving average is $97.28. Integer has a one year low of $62.00 and a one year high of $126.79. The firm has a market cap of $4.28 billion, a price-to-earnings ratio of 34.44, a PEG ratio of 2.40 and a beta of 0.62. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41.
Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.38 by $0.22. The firm had revenue of $464.11 million for the quarter, compared to analyst estimates of $451.07 million. Integer had a return on equity of 12.79% and a net margin of 6.97%.The company's revenue was down 2.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.55 earnings per share. Equities research analysts anticipate that Integer will post 6.09 EPS for the current year.
About Integer
(
Get Free Report)
Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.
Integer's medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.